Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis
Sign Up to like & getrecommendations! Published in 2018 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.01632-18
Abstract: The in vitro activity of tavaborole, an FDA-approved antifungal drug, was compared to that of four antifungal agents against 170 clinical fungal isolates originating from patients with onychomycosis. Tavaborole had low activity against all isolates… read more here.
Keywords: treatment onychomycosis; activity tavaborole; vitro antifungal; low vitro ... See more keywords